February 24, 2010Open Access

Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy

Key Points

Key points are not available for this paper at this time.

Abstract

The initiation of antiretroviral therapy during tuberculosis therapy significantly improved survival and provides further impetus for the integration of tuberculosis and HIV services. (ClinicalTrials.gov number, NCT00398996.)

Read Full Paperexternally

Bookmark

View Full Paper

Cite This Study

Karim et al. (Wed,) studied this question.

synapsesocial.com/papers/69dd62e326032fe00d100e22 https://doi.org/https://doi.org/10.1056/nejmoa0905848

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Influence of highly active anti-retroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patients.2002 · 26 citations
2Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies2009 · 746 citations
3Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa2001 · 315 citations
4Issues in the Treatment of Active Tuberculosis in Human Immunodeficiency Virus‐Infected Patients1999 · 32 citations
5Paradoxical Reactions in HIV and Pulmonary TB1998 · 102 citations

Bookmark

View Full Paper